Literature DB >> 15220821

Practical markers used in the diagnosis of endocrine tumors.

Lori A Erickson1, Ricardo V Lloyd.   

Abstract

Endocrine tumors constitute a large group of neoplasms that are widely dispersed throughout the body. They are made up mostly of neuroendocrine tumors (NE), which are characterized by the presence of secretory granules and production of peptide hormones, and non-NE tumors such as those derived from thyroid follicular cells and adrenal cortical cells. Immunohistochemical markers have been used to characterize these lesions and distinguish them from other histologically similar tumors. Chromogranin and synaptophysin are the most widely used broad-spectrum neuroendocrine tumor markers. The use of antibodies to transcription factors, keratins, and specific peptides is quite valuable in the diagnosis of endocrine tumors. This article reviews the common markers used to characterize endocrine tumors and to recognize tumors involved in the differential diagnosis of specific lesions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220821     DOI: 10.1097/01.pap.0000131824.77317.a7

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  18 in total

1.  Diagnostic value of neutrophil gelatinase-associated lipocalin (NGAL) immunoexpression in follicular-patterned lesions of the thyroid gland.

Authors:  Valeria Barresi; Enrica Vitarelli; Luca Reggiani Bonetti; Giovanni Tuccari; Gaetano Barresi
Journal:  Virchows Arch       Date:  2012-02-28       Impact factor: 4.064

2.  Composite hemangioendothelioma with neuroendocrine marker expression: an aggressive variant.

Authors:  Kyle D Perry; Alyaa Al-Lbraheemi; Brian P Rubin; Jin Jen; Hongzheng Ren; Jin Sung Jang; Asha Nair; Jaime Davila; Stefan Pambuccian; Andrew Horvai; William Sukov; Henry D Tazelaar; Andrew L Folpe
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842

3.  Preoperative assessment of the pancreas in multiple endocrine neoplasia type 1.

Authors:  Mark A Lewis; Geoffrey B Thompson; William F Young
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 4.  Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms.

Authors:  Georgios Kyriakopoulos; Vasiliki Mavroeidi; Eleftherios Chatzellis; Gregory A Kaltsas; Krystallenia I Alexandraki
Journal:  Ann Transl Med       Date:  2018-06

5.  Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.

Authors:  Ryan C Romano; Jodi M Carter; Andrew L Folpe
Journal:  Mod Pathol       Date:  2015-05-29       Impact factor: 7.842

6.  Markers of bile duct tumors.

Authors:  Giulia Malaguarnera; Maria Giordano; Isabella Paladina; Alessandra Rando; Mario Uccello; Francesco Basile; Antonio Biondi; Santo Carnazzo; Innocenza Alessandria; Clorinda Mazzarino
Journal:  World J Gastrointest Oncol       Date:  2011-04-15

7.  Evaluation of neuroendocrine markers in renal cell carcinoma.

Authors:  Hanna Ronkainen; Ylermi Soini; Markku H Vaarala; Saila Kauppila; Pasi Hirvikoski
Journal:  Diagn Pathol       Date:  2010-05-12       Impact factor: 2.644

8.  Clinicopathological analysis of paraganglioma with literature review.

Authors:  Ning Feng; Wen-Yan Zhang; Xiao-Ting Wu
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

9.  Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases.

Authors:  Bruna Estrozi; Carlos E Bacchi
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer.

Authors:  M Hammad Ather; Farhat Abbas; Nuzhat Faruqui; Mohammad Israr; Shahid Pervez
Journal:  BMC Urol       Date:  2008-12-30       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.